Skip to main content

Structured products

Tri-party repo push for Europe

Europe's tri-party repo market may be ready to take off, thanks to the combination of tighter credit conditions and the provision under Basel II, the new Accord on bank regulatory capital, for lower charges on collateralised financing.

CME cuts European fees

The Chicago Mercantile Exchange (CME) has slashed transaction fees for all products traded electronically on Globex in Europe, bringing its costs in line with rivals the Chicago Board of Trade (CBOT) and Eurex. However, the cut of 73% to 44 cents, from…

Self-regulation: Speak no evil

In an effort to head off any attempts by regulators to mount Spitzer-style investigations into credit research, banks under the aegis of the BMA are formulating proposals to self-regulate.

Sponsor's article > When is best practice good enough?

A dramatic change in banking regulation has been the move from prescriptive procedures towards 'best practice' risk management. Disagreements about how quickly the new approach can be applied to credit risk is central to arguments about revising Basel II.

EU explores rating agency shake-up

The European parliament may be set to tighten the regulation of credit rating agencies after a paper from the parliament's Committee on Economic and Monetary Affairs emphasised the growing significance of rating agencies in the financial systems and…

Insurers must do better - FSA

A new study by the UK's Financial Services Authority into risk management at insurance firms concludes that, although practices are improving in general, there is a long way to go before insurers are at the same standard as other types of financial…

CBOT chief again hits out at Eurex US

Chicago Board of Trade (CBOT) chairman Charles Carey urged the Commodity Futures Trading Commission to conduct a full and careful review of the application by Eurex to establish a US subsidiary yesterday. Carey’s comments are the latest in an ongoing…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here